| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Hing C. Wong | Chief Executive Officer, Director | $22.5M | Feb 20, 2024 | ||
| Rebecca Byam | Chief Financial Officer | $1.93M | Feb 20, 2024 | ||
| Scott T. Garrett | Director | $375K | Jun 14, 2024 | ||
| Lee Flowers | SVP of Business Development | $266K | Feb 20, 2024 | ||
| Peter Rhode | Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. | $161K | Dec 11, 2023 | ||
| Jin-an Jiao | VP of Development | $93.8K | May 31, 2022 | ||
| Rick S. Greene | Director | $61.8K | Jun 14, 2024 | ||
| Lisa M. Giles | Director | $50.1K | Jun 14, 2024 | ||
| Gary M. Winer | Director | $35.3K | Jun 14, 2024 | ||
| Medmira Capital Ltd. | 10%+ Owner | Sep 15, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|